Skip to main content
Clinical Trials/NCT01070537
NCT01070537CompletedPhase 2

INVIBO: Evaluation of the Feasibility and Tolerance of an Intubation Procedure Performed by Means of the Bonfils Fiberscope in Awake Patients With Predicted Difficult Intubation in the Context of ENT Cancer Surgery

Centre Leon Berard2 sites in 1 country41 target enrollmentStarted: February 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
41
Locations
2
Primary Endpoint
The rate of BFI meeting quality requirements: the procedure must be successful on the one hand (≤ 2 attempts and duration < 180 sec); and well tolerated on the other hand (Fahey score < 2).

Study Overview

Brief Summary

The Bonfils intubation fiberscope (BF), a rigid medical device with a curved tip, is exclusively used in anesthesiology for orotracheal intubation (OTI). The objective of the study was to evaluate the feasibility and the tolerance of an intubation procedure realized by means of the BF (BFI) in awake adult patients with predicted difficult intubation (PDI), in the context of ENT cancer surgery.

The intubation is performed under local anesthesia (either nasal, oral, or intercricothyroidal) and sedation using Remifentanyl (AIVOC) with spontaneous ventilation. The primary endpoint is the rate of BFI meeting quality requirements: the procedure must be both successful (≤ 2 attempts and duration < 180 sec) and well tolerated (Fahey score < 2). The secondary endpoints include the difficulties met by the operator during the BFI and patient's perception of the intubation procedure, evaluated in the recovery room and 7 days after the intervention. Sample size is calculated using a one-stage Fleming design with p0=80%, p1=95%, alpha=5% and 80% power, for a total of 32 evaluable patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male or female patients aged ≥ 18 years
  • Requiring a surgical intervention for an ENT carcinoma
  • Presenting with a PDI defined either as an Arne Score > 11, or a previous history of DI or by the surgeon's judgment.
  • Able to understand, read and write French
  • Signed, written informed consent

Exclusion Criteria

  • Impossible mask ventilation
  • Patient with a laryngeal stridor indicative of upper airway stenosis
  • Patient requiring an intubation by nasal route
  • Glasgow score < 12
  • BMI > 35
  • Pregnant or lactating women
  • Documented history of cognitive or psychiatric disorders
  • Difficult follow-up

Outcomes

Primary Outcomes

The rate of BFI meeting quality requirements: the procedure must be successful on the one hand (≤ 2 attempts and duration < 180 sec); and well tolerated on the other hand (Fahey score < 2).

Time Frame: 180 sec after the beginning of the intubation

Secondary Outcomes

  • Number of well-tolerated BFI procedures(At the end of the intubation)
  • Duration of the intubation procedure among patients with a successful BFI (≤ 2 attempts and duration < 180 sec)(At the end of the intubation)
  • Frequency and type of difficulties met by the operator(At the end of the intubation)
  • Frequency and type of adverse events experienced by the patient(At the end of the intubation)
  • Patient's perception of the intubation procedure(In the recovery room and 7 days after the intubation)

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Evaluation of the Bonfils Fiberscope for... | Clinical Trial